Iqvia and nrx pharmaceuticals collaborate on potential medical support for novel covid-19 treatment

Research triangle park, n.c.--(business wire)--iqvia™ (nyse:iqv), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a transformative collaboration with nrx pharmaceuticals (nrx) (nasdaq: nrxp). nrx is a company dedicated to creating innovative, life-saving treatments and bringing hope to those facing life-altering conditions with no approved disease-modifying therapies or cures. iqvia is excited to
IQV Ratings Summary
IQV Quant Ranking